RANBP2-ALK fusion combined with monosomy 7 in acute myelomonocytic leukemia

Cancer Genetics

Volumn 207, Issue 1-2, 2014, Pages 40-45

  Lim, Ji Hun ^a   Jang, Seongsoo ^a   Park, Chan Jeoung ^a   Cho, Young Uk ^a   Lee, Je Hwan ^a   Lee, Kyoo Hyung ^a   Lee, Jin Ok ^b   Shin, Jong Yeon ^c   Kim, Jong Il ^c   Huh, Jooryung ^a   Seo, Eul Ju ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Acute myelomonocytic leukemia; ALK; Fusion gene; Monosomy 7; RANBP2

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; NUCLEAR PROTEIN; RAN BINDING PROTEIN 2; RNA; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ACUTE MYELOMONOCYTIC LEUKEMIA; ADULT; ALK GENE; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CELL NUCLEUS MEMBRANE; CYTOGENETICS; DISEASE COURSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE FUSION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPE; LEUKEMIA CELL; MONOSOMY 7; PRIORITY JOURNAL; RANBP2 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE;

ACUTE MYELOMONOCYTIC LEUKEMIA; ALK; FUSION GENE; MONOSOMY 7; RANBP2;

ADULT; BONE MARROW CELLS; CHROMOSOME INVERSION; CHROMOSOMES, HUMAN, PAIR 7; FATAL OUTCOME; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOMONOCYTIC, ACUTE; MOLECULAR CHAPERONES; MONOSOMY; NUCLEAR PORE COMPLEX PROTEINS; ONCOGENE PROTEINS, FUSION; PROGNOSIS; RECEPTOR PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84896492577     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2013.12.003     Document Type: Article

References (22)

1. Morris S.W., Kirstein M.N., Valentine M.B., et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994, 263:1281-1284.
2. Arber D.A., Sun L.H., Weiss L.M. Detection of the t(2;5)(p23;q35) chromosomal translocation in large B-cell lymphomas other than anaplastic large cell lymphoma. Human Pathol 1996, 27:590-594.
3. Ma Z., Hill D.A., Collins M.H., et al. Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 2003, 37:98-105.
4. Griffin C.A., Hawkins A.L., Dvorak C., et al. Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors. Cancer Res 1999, 59:2776-2780.
5. Patel A.S., Murphy K.M., Hawkins A.L., et al. RANBP2 and CLTC are involved in ALK rearrangements in inflammatory myofibroblastic tumors. Cancer Genet Cytogenet 2007, 176:107-114.
6. Chen S.T., Lee J.C. An inflammatory myofibroblastic tumor in liver with ALK and RANBP2 gene rearrangement: combination of distinct morphologic, immunohistochemical, and genetic features. Hum Pathol 2008, 39:1854-1858.
7. Soda M., Choi Y.L., Enomoto M., et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007, 448:561-566.
8. Jazii F.R., Najafi Z., Malekzadeh R., et al. Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer. World J Gastroenterol 2006, 12:7104-7112.
9. Lin E., Li L., Guan Y., et al. Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers. Mol Cancer Res 2009, 7:1466-1476.
10. Iwahara T., Fujimoto J., Wen D., et al. Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system. Oncogene 1997, 14:439-449.
11. Pulford K., Lamant L., Morris S.W., et al. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood 1997, 89:1394-1404.
12. Mourali J., Benard A., Lourenco F.C., et al. Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage. Mol Cell Biol 2006, 26:6209-6222.
13. Rottgers S., Gombert M., Teigler-Schlegel A., et al. ALK fusion genes in children with atypical myeloproliferative leukemia. Leukemia 2010, 24:1197-1200.
14. ISCN 2009: an international system for human cytogenetic nomenclature 2009, Karger, Basel. L.G. Shaffer, M.L. Slovak, L.J. Campbell (Eds.).
15. Ju Y.S., Lee W.C., Shin J.Y., et al. Atransforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing. Genome Res 2012, 22:436-445.
16. Luna-Fineman S., Shannon K.M., Lange B.J. Childhood monosomy 7: epidemiology, biology, and mechanistic implications. Blood 1995, 85:1985-1999.
17. Hasle H., Alonzo T.A., Auvrignon A., et al. Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study. Blood 2007, 109:4641-4647.
18. Yaseen N.R., Blobel G. GTP hydrolysis links initiation and termination of nuclear import on the nucleoporin nup358. JBiol Chem 1999, 274:26493-26502.
19. Marino-Enriquez A., Wang W.L., Roy A., et al. Epithelioid inflammatory myofibroblastic sarcoma: an aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Am J Surg Pathol 2011, 35:135-144.
20. Laurent C., Do C., Gascoyne R.D., et al. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis. JClin Oncol 2009, 27:4211-4216.
21. Li R., Morris S.W. Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy. Med Res Rev 2008, 28:372-412.
22. Solomon B., Wilner K.D., Shaw A.T. Current status of targeted therapy for anaplastic lymphoma kinase (ALK) rearranged non-small cell lung cancer. Clin Pharmacol Ther 2013, 95:15-23.